Sumatriptan inhibits the release of CGRP and substance P from the rat spinal cord

被引:63
作者
Arvieu, L
Mauborgne, A
Bourgoin, S
Oliver, C
Feltz, P
Hamon, M
Cesselin, F
机构
[1] UNIV PARIS 06,INSERM U288,F-75634 PARIS 13,FRANCE
[2] FAC MED NORD,INSERM U297,F-13326 MARSEILLE 15,FRANCE
[3] UNIV STRASBOURG 1,CNRS URA 1446,F-67084 STRASBOURG,FRANCE
关键词
sumatriptan; substance P; calcitonin generated peptide; in vitro release; dorsal spinal cord;
D O I
10.1097/00001756-199608120-00023
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
THE possible presynaptic action of the anti-migraine drug sumatriptan on primary afferent fibres containing substance P and/or calcitonin gene-related peptide was investigated on superfused rat horizontal spinal cord slices with attached dorsal roots. Electrical stimulation of dorsal roots triggered a significant overflow of both peptides; this could be reduced by sumatriptan in a concentration-dependent manner. As expected from the involvement of 5-HT1B/(1D beta) receptors, methiothepin, (-)tertatolol and GR 127,935, but not WAY 100,635, prevented the inhibitory effect of sumatriptan. These data support the idea that the anti-migraine action of sumatriptan may involve, at least in part, a presynaptic inhibitory control of nociceptive (trigeminovascular) substance P- and/or calcitonin gene-related peptide-containing sensory fibres.
引用
收藏
页码:1973 / 1976
页数:4
相关论文
共 25 条
[1]   (-)-Pindolol and (+/-)-tertatolol affect rat hippocampal 5-HT levels through mechanisms involving not only 5-HT1A, but also 5-HT1B receptors [J].
Assie, MB ;
Koek, W .
NEUROPHARMACOLOGY, 1996, 35 (02) :213-222
[2]   THE MOUSE 5-HYDROXYTRYPTAMINE(1B) RECEPTOR IS LOCALIZED PREDOMINANTLY ON AXON TERMINALS [J].
BOSCHERT, U ;
AMARA, DA ;
SEGU, L ;
HEN, R .
NEUROSCIENCE, 1994, 58 (01) :167-182
[3]   EVIDENCE FOR THE PRESENCE OF 5-HT(1B) RECEPTOR MESSENGER-RNA IN NEURONS OF THE RAT TRIGEMINAL GANGLIA [J].
BRUINVELS, AT ;
LANDWEHRMEYER, B ;
MOSKOWITZ, MA ;
HOYER, D .
EUROPEAN JOURNAL OF PHARMACOLOGY-MOLECULAR PHARMACOLOGY SECTION, 1992, 227 (03) :357-359
[4]   EVOLUTION OF A NOVEL SERIES OF [(N,N-DIMETHYLAMINO)PROPYL]ANILIDE AND PIPERAZINYLBENZANILIDES AS THE FIRST SELECTIVE 5-HT1D ANTAGONISTS [J].
CLITHEROW, JW ;
SCOPES, DIC ;
SKINGLE, M ;
JORDAN, CC ;
FENIUK, W ;
CAMPBELL, IB ;
CARTER, MC ;
COLLINGTON, EW ;
CONNOR, HE ;
HIGGINS, GA ;
BEATTIE, D ;
KELLY, HA ;
MITCHELL, WL ;
OXFORD, AW ;
WADSWORTH, AH ;
TYERS, MB .
JOURNAL OF MEDICINAL CHEMISTRY, 1994, 37 (15) :2253-2257
[5]   IN-SITU HYBRIDIZATION EVIDENCE FOR THE SYNTHESIS OF 5-HT1B RECEPTOR IN SEROTONINERGIC NEURONS OF ANTERIOR RAPHE NUCLEI IN THE RAT-BRAIN [J].
DOUCET, E ;
POHL, M ;
FATTACCINI, CM ;
ADRIEN, J ;
ELMESTIKAWY, S ;
HAMON, M .
SYNAPSE, 1995, 19 (01) :18-28
[6]   HETEROGENEOUS EFFECTS OF SEROTONIN IN THE DORSAL HORN OF RAT - THE INVOLVEMENT OF 5-HT1-RECEPTOR SUBTYPES [J].
ELYASSIR, N ;
FLEETWOODWALKER, SM ;
MITCHELL, R .
BRAIN RESEARCH, 1988, 456 (01) :147-158
[7]  
Fletcher A, 1996, BEHAV BRAIN RES, V73, P337
[8]   THE TRIGEMINOVASCULAR SYSTEM AND MIGRAINE - STUDIES CHARACTERIZING CEREBROVASCULAR AND NEUROPEPTIDE CHANGES SEEN IN HUMANS AND CATS [J].
GOADSBY, PJ ;
EDVINSSON, L .
ANNALS OF NEUROLOGY, 1993, 33 (01) :48-56
[9]  
HAMEL E, 1993, MOL PHARMACOL, V44, P242
[10]   SPECIES-DIFFERENCES IN THE PHARMACOLOGY OF TERMINAL 5-HT AUTORECEPTORS IN MAMMALIAN BRAIN [J].
HOYER, D ;
MIDDLEMISS, DN .
TRENDS IN PHARMACOLOGICAL SCIENCES, 1989, 10 (04) :130-132